A 50-year-old with new CDI and prior recurrence risk factors (age 65, recent hospitalization) asks about adjunctive therapy to reduce recurrence risk...

Question

A 50-year-old with new CDI and prior recurrence risk factors (age >65, recent hospitalization) asks about adjunctive therapy to reduce recurrence risk along with standard antibiotics. What is recommended?

Accepted Answer

Bezlotoxumab as adjunctive therapy in high-risk patients

Answer

Probiotics

Answer

Cholestyramine

Answer

Fecal microbiota transplantation as first-line

Answer

Prolonged metronidazole suppression

us-abim MCQ (SBA): Clostridioides difficile-Recurrence Prevention

A 50-year-old with new CDI and prior recurrence risk factors (age >65, recent hospitalization) asks about adjunctive therapy to reduce recurrence risk along with standard antibiotics. What is recommended?